Table of Contents Author Guidelines Submit a Manuscript
Arthritis
Volume 2015, Article ID 784825, 7 pages
http://dx.doi.org/10.1155/2015/784825
Research Article

Antibodies to Infliximab and Adalimumab in Patients with Rheumatoid Arthritis in Clinical Remission: A Cross-Sectional Study

1Department of Clinical Biochemistry, Copenhagen University Hospital at Køge, 4600 Køge, Denmark
2Department of Rheumatology, Copenhagen University Hospital at Køge, 4600 Køge, Denmark
3The Parker Institute, Department of Rheumatology, Copenhagen University Hospitals at Frederiksberg and Bispebjerg, 2000 Copenhagen F, Denmark
4Institute for Inflammation Research (IIR), Rigshospitalet University Hospital, 2100 Copenhagen, Denmark
5DANBIO registry, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup, 2600 Glostrup, Denmark
6Department of Rheumatology, Copenhagen University Hospital Glostrup, 2600 Glostrup, Denmark
7Department of Rheumatology, Odense University Hospital, 5000 Odense, Denmark
8Department of Rheumatology, Copenhagen University Hospitals at Frederiksberg and Bispebjerg, 2000 Frederiksberg, Denmark
9Department of Rheumatology, Copenhagen University Hospital at Gentofte, 2900 Gentofte, Denmark
10Department of Rheumatology, Copenhagen University Hospital at Holbæk, 4300 Holbæk, Denmark

Received 22 December 2014; Accepted 30 January 2015

Academic Editor: Alejandro Balsa

Copyright © 2015 Grith P. Eng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Grith P. Eng, Klaus Bendtzen, Henning Bliddal, et al., “Antibodies to Infliximab and Adalimumab in Patients with Rheumatoid Arthritis in Clinical Remission: A Cross-Sectional Study,” Arthritis, vol. 2015, Article ID 784825, 7 pages, 2015. https://doi.org/10.1155/2015/784825.